Neurology 49(6):16211630 Borasio GD, Robberecht W, Leigh PN, Emile J, Guiloff RJ, Jerusalem F, Silani V, Vos PE, Wokke JH, Dobbins T (1998) A placebo-controlled trial of insulin-like growth factor-i in amyotrophic lateral sclerosis
The peptide has been the subject of extensive biochemical and cellular research literature
These medications, known for their effectiveness in weight management, are administered under the supervision of our experienced network of medical professionals
There was no finding that the lack of specified testing was associated with any adverse event, the pharmacy said
Cancer susceptibility and embryonic lethality in Mob1a/1b double-mutant mice
What some people experience is rebound oxidative stress, which is the return to baseline antioxidant status after temporary augmentation, not a true withdrawal syndrome